Updates are available Correction dated 2023-09-06
Click to view Correction: https://doi.org/10.1038/s41536-023-00323-1
-
Authors
Zhang, Wencheng http://orcid.org/0000-0003-2848-1611
Wang, Xicheng http://orcid.org/0000-0001-6677-850X
Lanzoni, Giacomo
Wauthier, Eliane
Simpson, Sean
Ezzell, Jennifer Ashley
Allen, Amanda
Suitt, Carolyn
Krolik, Jonah
Jhirad, Alexander
Dominguez-Bendala, Juan http://orcid.org/0000-0001-9410-9143
Cardinale, Vincenzo
Alvaro, Domenico
Overi, Diletta
Gaudio, Eugenio
Sethupathy, Praveen http://orcid.org/0000-0001-9887-8871
Carpino, Guido http://orcid.org/0000-0001-8570-2519
Adin, Christopher http://orcid.org/0000-0001-7677-7711
Piedrahita, Jorge A
Mathews, Kyle
He, Zhiying
Reid, Lola McAdams http://orcid.org/0000-0001-5956-6242
- License Information
-
More Information
Article History
Received: 16 May 2022
Accepted: 23 May 2023
First Online: 1 August 2023
Change Date: 6 September 2023
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41536-023-00323-1
Competing interests
: Several of the authors are inventors of numerous patents on human hepatic and biliary tree stem cells and on grafting strategies for transplantation of organoids or cell suspensions into solid organs. These are owned by UNC and some also indicate rights to Sapienza University and to the University of Miami. The clinical uses in humans of the IP are licensed to Vesta Therapeutics (Bethesda, MD), and the clinical uses in non-humans (veterinary uses) and the non-clinical, commercial uses are licensed to PhoenixSongs Biologicals (Branford, CT). No authors have equity in Vesta Therapeutics or in PhoenixSongs Biologicals; nor have a position within the company; and none have been provided payments for consulting. The only exception is that L.M.R. is one of the founders of PhoenixSongs Biologicals and has an equity position in the company but does not receive salary, consulting, or research funds from the company. Once patents were filed, all information has been made available with full disclosures in publications and in oral presentations. Independent of the comments above, the authors declare there are no competing interests.
